Aclaris Therapeutics, Inc

(NASDAQ:ACRS)

Latest On Aclaris Therapeutics, Inc (ACRS):

Date/Time Type Description Signal Details
2023-05-08 20:31 ESTNewsAclaris Therapeutics, Inc. (ACRS) Q1 2023 Earnings Call TranscriptN/A
2023-05-08 07:15 ESTNewsAclaris Therapeutics GAAP EPS of -$0.42 beats by $0.02, revenue of $2.53M beats by $0.78MN/A
2023-05-05 23:32 ESTNewsAclaris Therapeutics Q1 2023 Earnings PreviewN/A
2023-03-09 12:31 ESTNewsAclaris Therapeutics: Potential Speculative Play After Zunsemetinib Misses Mark On Hidradenitis SuppurativaN/A
2023-03-06 10:16 ESTNewsAclaris stock falls ~35% as zunsemetinib fails mid-stage study in skin disorderN/A
2023-02-23 11:16 ESTNewsAclaris Therapeutics GAAP EPS of -$0.41 beats by $0.05, revenue of $7.75M beats by $5.76MN/A
2023-01-12 19:02 ESTNewsAclaris Therapeutics (ACRS) Presents at the 41st Annual J.P. Morgan Healthcare Conference -- SlideshowN/A
2023-01-10 19:15 ESTNewsAclaris Therapeutics Has Strong Upside Potential, But Shares Could Be LowerN/A
2022-12-02 00:46 ESTNewsGoldman Sachs initiates Aclaris at Buy citing potential in lead assetN/A
2022-11-23 08:47 ESTNewsAclaris Therapeutics names CEO as board chair, COO to take helmN/A
2022-10-06 22:31 ESTNewsAclaris initiated as a buy at BTIG on potential of zunsemetinib for autoimmune conditionsN/A
2022-08-26 00:31 ESTNewsAclaris, Lilly ink patent license deal for Olumiant to treat alopecia areataN/A
2022-08-03 16:47 ESTNewsAclaris Therapeutics GAAP EPS of -$0.31 beats by $0.05, revenue of $1.53M misses by $0.08MN/A
2022-08-01 21:32 ESTNewsAclaris Therapeutics gets a new COON/A
2022-06-27 23:02 ESTNewsAclaris Therapeutics appoints Gail Cawkwell as Chief Medical OfficerN/A
2022-05-10 22:48 ESTNewsAclaris Therapeutics GAAP EPS of -$0.31 beats by $0.09, revenue of $1.45M misses by $0.22MN/A
2022-02-24 08:00 ESTNewsAclaris Therapeutics GAAP EPS of -$0.37 misses by $0.01, revenue of $1.5M misses by $0.3MN/A
2022-02-23 12:00 ESTNewsAclaris Therapeutics Q4 2021 Earnings PreviewN/A
2022-02-01 22:01 ESTNewsAclaris Therapeutics appoints chief business officerN/A
2022-01-12 00:16 ESTNewsAclaris falls on the exit of medical chiefN/A
2021-11-02 11:16 ESTNewsAclaris Therapeutics EPS misses by $0.07, misses on revenueN/A
2021-10-02 05:32 ESTNewsAclaris Therapeutics (ACRS) Investor Presentation - SlideshowN/A
2021-09-17 12:18 ESTNewsAclaris Therapeutics (ACRS) Presents At 23rd Annual Global Investment Virtual Conference - SlideshowN/A
2021-08-27 23:16 ESTNewsAclaris announces proposed settlement of shareholder derivative actionN/A
2021-08-05 21:07 ESTNewsAclaris Therapeutics EPS misses by $0.06, beats on revenueN/A
2021-07-24 07:16 ESTNewsAclaris price target raised at Jefferies citing ‘significant stock moving event’N/A
2021-07-20 17:52 ESTNewsAclaris Therapeutics posts promising data from mid-stage atopic dermatitis trialN/A
2021-07-20 17:51 ESTNewsAclaris Therapeutics to raise $75M in stock offeringN/A
2021-07-20 17:51 ESTNewsAclaris to offer $75M in public offering of stock; shares down 16%N/A
2021-07-20 17:49 ESTNewsAclaris to meet competition from Incyte in atopic dermatitisN/A
2021-07-20 17:49 ESTNewsAclaris Therapeutics secures $125M capital via equity raiseN/A
2021-05-07 23:03 ESTNewsAclaris Therapeutics EPS misses by $0.29, beats on revenueN/A
2021-03-16 16:01 ESTNewsAclaris Therapeutics (ACRS) Presents At H.C. Wainwright Global Life Sciences Virtual Conference - SlideshowN/A
2021-03-15 16:01 ESTNewsAclaris completes enrollment of mid-stage trial for atopic dermatitisN/A
2021-03-05 15:01 ESTAnalyst RatingThe Analyst Target Price has increased from $25 to $26.67.Buy
2021-03-03 02:01 ESTNewsAclaris Therapeutics: A Potential Big Pharma Deal May Be In The HorizonN/A
2021-02-26 15:01 ESTFinancialsCompany financials have been released.Neutral
2021-02-26 03:01 ESTEarnings EstimateAn EPS average of -$1.04 is estimated for the 2022 year.Sell
2021-02-26 03:01 ESTEarnings EstimateAn EPS average of -$0.28 is estimated for the quarter ending on June 30, 2021.Buy
2021-02-25 18:35 ESTNewsAclaris Therapeutics EPS misses by $0.04, beats on revenueN/A
2021-02-22 16:16 ESTNewsAclaris Therapeutics stock spikes after speculation of potential sale (update)N/A
2021-02-02 11:01 ESTAnalyst RatingThe Analyst Target Price has increased from $20 to $25.Buy
2021-01-21 11:01 ESTAnalyst RatingThe Analyst Target Price has increased from $14 to $20.Buy
2021-01-20 13:32 ESTNewsAclaris shares rise 10% after pricing equity offeringN/A
2021-01-20 11:01 ESTAnalyst RatingThe Analyst Target Price has increased from $5.83 to $14.Neutral
2021-01-19 23:31 ESTNewsAclaris Therapeutics readies proposed public offeringN/A
2021-01-19 08:31 ESTNewsAclaris stock surges on positive data from mid-stage rheumatoid arthritis ATI-450 trialN/A
2021-01-16 11:00 ESTNewsStocks To Watch: Earnings Day For Netflix, Intel And Procter & GambleN/A
2020-12-22 11:01 ESTAnalyst RatingThe Analyst Target Price has increased from $5.5 to $5.83.Neutral
2020-12-17 11:01 ESTAnalyst RatingThe Analyst Target Price has increased from $4.83 to $5.5.Buy

About Aclaris Therapeutics, Inc (ACRS):

Aclaris Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing drug candidates for immuno-inflammatory diseases in the United States. The Company operates in two segments, Therapeutics and Contract Research. Its products pipeline includes ATI-450, an investigational oral, novel, small molecule selective MK2 inhibitor compound that is in phase 2 clinical trial for the treatment of moderate to severe rheumatoid arthritis, COVID-19, and additional immuno-inflammatory diseases; ATI-1777, an investigational topical soft JAK 1/3 inhibitor compound, which is in phase 2a clinical trial to treat moderate to severe atopic dermatitis; and ATI-2138, an investigational oral ITK/TXK/JAK3 inhibitor compound for the treatment for psoriasis and/or inflammatory bowel disease, as well as A-101 45% topical solution to treat common warts. It also provides contract research services. Aclaris Therapeutics, Inc. has a license and collaboration agreement with Rigel Pharmaceuticals, Inc. for the development and commercialization of JAK inhibitors. The company was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.

ACRS Quotes by TradingView

See Advanced Chart

General

  • Name Aclaris Therapeutics, Inc
  • Symbol ACRS
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 57
  • Fiscal Year EndDecember
  • IPO Date2015-10-07
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.aclaristx.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 156.98
  • Price/Book (Most Recent Quarter) 32.91
  • Enterprise Value Revenue 184.55
  • Enterprise Value EBITDA 0.05
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.05
  • Next Year EPS Estimate -$1.38
  • Operating Margin -749%
  • Return on Assets -36%
  • Return on Equity -95%
  • Revenue 6.48 million
  • Earnings Per Share -$4.17
  • Revenue Per Share $0.15
  • Gross Profit -27989000
  • Quarterly Earnings Growth 44.3%
View More

Highlights

  • Market Capitalization 1.29 billion
  • EBITDA -134348000
  • PE Ratio -1.43
  • PEG Ratio -0.13
  • Analyst Target Price $26.67
  • Book Value Per Share $0.84
View More

Share Statistics

  • Shares Outstanding 51.8 million
  • Shares Float 35.44 million
  • % Held by Insiders 964%
  • % Held by Institutions 66.13%
  • Shares Short 758989
  • Shares Short Prior Month 1.45 million
  • Short Ratio 0.72
  • Short % of Float 2%
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta 0.66
  • 52 Week High $26.5
  • 52 Week Low $0.85
  • 50 Day Moving Average 22.3
  • 200 Day Moving Average 9.26
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Aclaris Therapeutics, Inc (ACRS) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Aclaris Therapeutics, Inc (ACRS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$1.58 million-$0.30-$0.26-15.38%
2020-09-302020-11-04$1.45 million-$0.25-$0.3118.03%
2020-06-302020-08-07$N/A-$0.28-$0.3621.13%
2020-03-312020-05-07$1.41 million-$0.37-$0.381.33%
2019-12-312020-02-25$1.1 million-$0.45-$0.39-16.37%
2019-09-302019-11-07$983000-$1.34-$0.69-94.2%
2019-06-302019-08-08$5.87 million-$1.21-$0.75-62.2%
2019-03-312019-05-08$5.04 million-$0.91-$0.80-13.4%
2018-12-312019-03-18$3.67 million-$0.99-$0.98-0.68%
2018-09-302018-11-06$1.63 million-$1.06-$1.3320.1%
2018-06-302018-08-03$3.68 million-$1.01-$1.097.62%
2018-03-312018-05-08$1.12 million-$0.98-$1.002.32%
2017-12-312018-03-12$999000-$0.74-$0.8815.91%
2017-09-302017-11-07$684000-$0.63-$0.8727.59%
2017-06-302017-08-08$N/A-$0.56-$0.7323.29%
2017-03-312017-05-09$N/A-$0.48-$0.5918.64%
2016-12-312017-03-15$N/A-$0.49-$0.6422.83%
2016-09-302016-11-03$N/A-$0.50-$0.6725.65%
2016-06-302016-08-11$N/A-$0.62-$0.654.13%
2016-03-312016-05-11$N/A-$0.65-$0.50-30%
2015-12-312016-03-23$N/A-$0.28-$0.4537.78%
2015-09-302015-10-13$N/A-$5.11-$2.84-79.93%

Aclaris Therapeutics, Inc (ACRS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development 8.96 million 6.87 million N/A 9.44 million 64.9 million
Income Before Tax -13.78 million -10.66 million N/A -15.33 million -19.45 million
Selling General Administrative 4.9 million 3.86 million N/A 6.2 million 6.61 million
Gross Profit 294000 260000 N/A 138000 52.36 million
Ebit -13.78 million -9.87 million N/A -14.93 million -19.14 million
Operating Income -13.56 million -10.47 million N/A -15.51 million -19.14 million
Income Tax Expense -182000 N/A N/A N/A N/A
Total Revenue 1.58 million 1.45 million N/A 1.41 million 1.1 million
Cost of Revenue 1.29 million 1.19 million N/A 1.27 million -51.27 million
Total Other Income Expense Net N/A -194000 N/A 178000 -305000
Net Income From Continuing Operations -13.6 million -10.66 million N/A -15.33 million -19.45 million
Net Income Applicable to Common Shares -13.17 million N/A -11.6 million -15.59 million -18.59 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments 5.24 million -10.49 million N/A 22.52 million N/A
Change to Liabilities N/A N/A -4.32 million -6.21 million N/A
Total Cash Flow from Investing Activities N/A N/A 13.94 million 56.44 million N/A
Net Borrowings N/A N/A 10.89 million -30.13 million N/A
Total Cash Flow from Financial Activities -278000 -97000 N/A -30.01 million N/A
Change to Operating Activities N/A N/A 2.57 million -9.43 million N/A
Change in Cash -7.19 million -21.41 million N/A 6.04 million N/A
Total Cash from Operating Activities -12.15 million -10.82 million -6.81 million -20.39 million N/A
Depreciation 591000 606000 N/A 5.05 million N/A
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A 3000 N/A
Change to Account Receivables -112000 158000 N/A 12.19 million N/A
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income N/A N/A 5.22 million -3.4 million N/A
Capital Expenditures 304000 17000 N/A 266000 N/A
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities 33.13 million 31.15 million 35.63 million 38.64 million 28.39 million
Total Stockholder Equity 37.65 million 40.76 million 49.37 million 58.18 million 69.91 million
Other Current Liabilities 3.71 million 3.3 million 2.29 million 2.66 million 4.16 million
Total Assets 70.78 million 71.9 million 85 million 96.81 million 98.3 million
Common Stock N/A N/A N/A N/A N/A
Other Current Assets 2.59 million 1.75 million N/A N/A 4.97 million
Retained Earnings -504.54 million -491.37 million -480.71 million -469.11 million -453.53 million
Other Liabilities N/A 7.74 million N/A 4.06 million 5.95 million
Other Assets N/A 4.84 million N/A 151000 4.83 million
Cash 22.06 million 23.64 million 32.59 million 53.99 million 35.94 million
Total Current Liabilities 14.87 million 12.79 million 17.75 million 20.6 million 22.43 million
Other Stockholder Equity -94000 -44000 N/A 47000 -66000
Property, Plant & Equipment 1.65 million 1.92 million N/A 6.77 million 2.47 million
Total Current Assets 57.49 million 58 million 70.96 million 82.71 million 83.8 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 30.53 million 33.62 million 51 million 51 million 62.71 million
Short Term Investments 32.07 million 29.83 million 35.53 million 25.01 million 39.08 million
Long Term Debt 10.65 million 10.61 million 10.57 million 10.57 million N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 11.16 million 5.08 million 5.5 million 6.95 million 9.92 million

Aclaris Therapeutics, Inc (ACRS) Chart:

Aclaris Therapeutics, Inc (ACRS) News:

Below you will find a list of latest news for Aclaris Therapeutics, Inc (ACRS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Aclaris Therapeutics, Inc (ACRS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-06-1813.7CALL0 0460.6TRUE00
2026-06-1822.8CALL0 7322.97TRUE00
2026-06-1832.13CALL0 6229.24TRUE00
2026-06-1841.14CALL0 13134.89TRUE00
2026-06-1850.17CALL19 338105.8FALSE0.170
2026-06-1860.1CALL0 53134.97FALSE00
2026-06-1870.05CALL0 21310.09FALSE00
2026-06-1880.05CALL0 23348.27FALSE00
2026-06-1810PUT0 0868.37FALSE00
2026-06-1820PUT0 0482.5FALSE00
2026-06-1830.11PUT0 108113.56FALSE00
2026-06-1840.25PUT700 78296.63FALSE0.250
2026-06-1850.65PUT0 2061.57TRUE00
2026-06-1860PUT0 00TRUE00
2026-06-1870PUT0 00TRUE00
2026-06-1880PUT0 00TRUE00
2026-07-1710CALL0 0277.1TRUE00
2026-07-1720CALL0 0247.58TRUE00
2026-07-1730CALL0 0130.82TRUE00
2026-07-1740CALL0 0116.41TRUE00
2026-07-1750.55CALL1 1106.54FALSE0.550
2026-07-1760.3CALL0 24114.08FALSE00
2026-07-1770.2CALL0 5156.1FALSE00
2026-07-1780CALL0 0188.13FALSE00
2026-07-1790CALL0 0206.88FALSE00
2026-07-1710PUT0 0528.95FALSE00
2026-07-1720PUT0 0294.12FALSE00
2026-07-1730PUT0 0176.98FALSE00
2026-07-1740.38PUT0 3117.75FALSE00
2026-07-1750PUT0 0120.61TRUE00
2026-07-1760PUT0 069.8TRUE00
2026-07-1770PUT0 00TRUE00
2026-07-1780PUT0 00TRUE00
2026-07-1790PUT0 00TRUE00
2026-08-2110CALL0 1276.96TRUE00
2026-08-2123.16CALL0 9213.86TRUE00
2026-08-2130CALL0 11140.78TRUE00
2026-08-2141.2CALL0 32130.55TRUE00
2026-08-2150.85CALL0 843107.36FALSE00
2026-08-2160CALL0 6115.85FALSE00
2026-08-2170.45CALL0 3120.75FALSE00
2026-08-2180.15CALL0 142137.68FALSE00
2026-08-2110PUT0 0399.56FALSE00
2026-08-2120PUT0 15222.36FALSE00
2026-08-2130PUT0 78134.05FALSE00
2026-08-2140.56PUT0 389.56FALSE00
2026-08-2151.1PUT0 1101.36TRUE00
2026-08-2160PUT0 096.67TRUE00
2026-08-2170PUT0 094.62TRUE00
2026-08-2180PUT0 0100.73TRUE00
2026-11-2010CALL0 0187.47TRUE00
2026-11-2020CALL0 0182.34TRUE00
2026-11-2032.38CALL0 6147.61TRUE00
2026-11-2040CALL0 1126.33TRUE00
2026-11-2051.5CALL0 10123.72FALSE00
2026-11-2060CALL0 0123.2FALSE00
2026-11-2070CALL0 12130.54FALSE00
2026-11-2080.8CALL0 13125.97FALSE00
2026-11-2010PUT0 0275.84FALSE00
2026-11-2020PUT0 0153.84FALSE00
2026-11-2030PUT0 0127.54FALSE00
2026-11-2040PUT0 0124.11FALSE00
2026-11-2050PUT0 1122.82TRUE00
2026-11-2060PUT0 0116.94TRUE00
2026-11-2070PUT0 0125.1TRUE00
2026-11-2080PUT0 0111.94TRUE00
2026-12-180.50CALL0 3271.48TRUE00
2026-12-1810CALL0 1209.79TRUE00
2026-12-181.50CALL0 11199TRUE00
2026-12-1823.2CALL0 1883168.51TRUE00
2026-12-1830CALL0 1628130.57TRUE00
2026-12-1841.7CALL0 703125.84TRUE00
2026-12-1851.8CALL0 306122.5FALSE00
2026-12-1860CALL0 21121.75FALSE00
2026-12-1870CALL0 1116.83FALSE00
2026-12-1881CALL0 4120.55FALSE00
2026-12-180.50.17PUT0 8305.86FALSE00
2026-12-1810PUT0 3256.38FALSE00
2026-12-181.50PUT0 3186.11FALSE00
2026-12-1820PUT0 1160.51FALSE00
2026-12-1830PUT0 211110.16FALSE00
2026-12-1840PUT0 1915113.46FALSE00
2026-12-1850PUT0 2116.69TRUE00
2026-12-1860PUT0 0117.19TRUE00
2026-12-1870PUT0 0109.15TRUE00
2026-12-1880PUT0 0105.07TRUE00
2027-01-1513.8CALL0 57161.22TRUE00
2027-01-1523.29CALL0 48141.04TRUE00
2027-01-1530CALL0 24119.15TRUE00
2027-01-1541.9CALL0 125126.21TRUE00
2027-01-1551.7CALL0 70114.43FALSE00
2027-01-1560CALL0 0113.76FALSE00
2027-01-1570CALL0 28116.5FALSE00
2027-01-1580CALL0 0112.67FALSE00
2027-01-1510PUT0 0240.57FALSE00
2027-01-1520PUT0 0150.71FALSE00
2027-01-1530.65PUT0 1114.33FALSE00
2027-01-1540PUT0 3111FALSE00
2027-01-1550PUT0 0117.58TRUE00
2027-01-1560PUT0 0110.49TRUE00
2027-01-1570PUT0 0110.51TRUE00
2027-01-1580PUT0 0107.26TRUE00
2027-03-1910CALL0 0172.37TRUE00
2027-03-1920CALL0 0152.83TRUE00
2027-03-1932.7CALL50 0126.48TRUE2.70
2027-03-1940CALL0 0141.25TRUE00
2027-03-1950CALL0 0128.76FALSE00
2027-03-1970CALL0 0128.64FALSE00
2027-03-1910PUT0 0251.74FALSE00
2027-03-1920PUT0 0152.15FALSE00
2027-03-1930PUT0 0138.52FALSE00
2027-03-1940PUT0 0126.45FALSE00
2027-03-1950PUT0 0122.75TRUE00
2027-03-1970PUT0 0112.53TRUE00
2027-12-1714.36CALL0 10212.65TRUE00
2027-12-1720CALL0 0164.36TRUE00
2027-12-1730CALL0 0130.37TRUE00
2027-12-1743.4CALL0 31133.64TRUE00
2027-12-1752.55CALL0 1127.17FALSE00
2027-12-1772.1CALL0 12124.3FALSE00
2027-12-1710PUT0 0184.5FALSE00
2027-12-1720PUT0 0144.98FALSE00
2027-12-1730PUT0 0133.67FALSE00
2027-12-1740PUT0 0128.96FALSE00
2027-12-1750PUT0 0119.67TRUE00
2027-12-1770PUT0 0120.19TRUE00

Latest ACRS Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST80$12.925
Jun 13, 2022 7:59 PM EST22$12.935
Jun 13, 2022 7:59 PM EST19$12.93
Jun 13, 2022 7:59 PM EST24$12.93
Jun 13, 2022 7:59 PM EST5$12.93

Aclaris Therapeutics, Inc (ACRS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090266420002531/0000902664-20-002531-index.htm
2020-03-19UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1557746/000000000020002443/0000000000-20-002443-index.htm
2019-01-25SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000003877719000005/0000038777-19-000005-index.htm
2020-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000003877720000013/0000038777-20-000013-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000021545719003192/0000215457-19-003192-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000031506619000849/0000315066-19-000849-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000031506620000819/0000315066-20-000819-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000083423720004757/0000834237-20-004757-index.htm
2020-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000083423720009989/0000834237-20-009989-index.htm
2019-08-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000089542119000589/0000895421-19-000589-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000089542120000139/0000895421-20-000139-index.htm
2020-03-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000089542120000278/0000895421-20-000278-index.htm
2020-06-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090266420002531/0000902664-20-002531-index.htm
2019-10-31SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090445419000691/0000904454-19-000691-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090445420000171/0000904454-20-000171-index.htm
2020-07-22SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090445420000503/0000904454-20-000503-index.htm
2019-07-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090514819000691/0000905148-19-000691-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090514820000306/0000905148-20-000306-index.htm
2019-01-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000091957419000663/0000919574-19-000663-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000091957420001125/0000919574-20-001125-index.htm
2019-10-15SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1557746/000092189519002554/0000921895-19-002554-index.htm
2019-11-21SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1557746/000092189519002853/0000921895-19-002853-index.htm
2019-12-19SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1557746/000092189519003037/0000921895-19-003037-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000093583620000140/0000935836-20-000140-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000103738920000090/0001037389-20-000090-index.htm
2019-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000110465919049176/0001104659-19-049176-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000110465920021847/0001104659-20-021847-index.htm
2020-03-06SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000110465920030172/0001104659-20-030172-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000110465920033094/0001104659-20-033094-index.htm
2020-03-13S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1557746/000110465920033140/0001104659-20-033140-index.htm
2020-04-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1557746/000110465920050082/0001104659-20-050082-index.htm
2020-04-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1557746/000110465920053341/0001104659-20-053341-index.htm
2020-08-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1557746/000110465920094778/0001104659-20-094778-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000110465920094781/0001104659-20-094781-index.htm
2020-10-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000110465920118249/0001104659-20-118249-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000114420419008093/0001144204-19-008093-index.htm
2019-07-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000117266119001597/0001172661-19-001597-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000117266120000734/0001172661-20-000734-index.htm
2020-10-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000117266120002035/0001172661-20-002035-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380518001435/0001193805-18-001435-index.htm
2018-12-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380518001441/0001193805-18-001441-index.htm
2019-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000014/0001193805-19-000014-index.htm
2019-01-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000067/0001193805-19-000067-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000181/0001193805-19-000181-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000485/0001193805-19-000485-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2019-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000603/0001193805-19-000603-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000616/0001193805-19-000616-index.htm
2019-07-31SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000689/0001193805-19-000689-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000119380520000193/0001193805-20-000193-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063368/0001209191-18-063368-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063369/0001209191-18-063369-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063370/0001209191-18-063370-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063372/0001209191-18-063372-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063373/0001209191-18-063373-index.htm
2018-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063795/0001209191-18-063795-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063801/0001209191-18-063801-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063802/0001209191-18-063802-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063803/0001209191-18-063803-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063804/0001209191-18-063804-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063805/0001209191-18-063805-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119007485/0001209191-19-007485-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119007486/0001209191-19-007486-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119007487/0001209191-19-007487-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119007488/0001209191-19-007488-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119007489/0001209191-19-007489-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119007490/0001209191-19-007490-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119015882/0001209191-19-015882-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119015888/0001209191-19-015888-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119015892/0001209191-19-015892-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119015894/0001209191-19-015894-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119015898/0001209191-19-015898-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119035829/0001209191-19-035829-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119035830/0001209191-19-035830-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119035832/0001209191-19-035832-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119035835/0001209191-19-035835-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119035840/0001209191-19-035840-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119035916/0001209191-19-035916-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119041173/0001209191-19-041173-index.htm
2019-07-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119041174/0001209191-19-041174-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119041175/0001209191-19-041175-index.htm
2019-10-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119054623/0001209191-19-054623-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119061067/0001209191-19-061067-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119061068/0001209191-19-061068-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119061069/0001209191-19-061069-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119061536/0001209191-19-061536-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119061540/0001209191-19-061540-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119061545/0001209191-19-061545-index.htm
2020-01-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120002761/0001209191-20-002761-index.htm
2020-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120002767/0001209191-20-002767-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120006666/0001209191-20-006666-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120006667/0001209191-20-006667-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120006668/0001209191-20-006668-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016065/0001209191-20-016065-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016073/0001209191-20-016073-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016076/0001209191-20-016076-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016078/0001209191-20-016078-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016081/0001209191-20-016081-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016084/0001209191-20-016084-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016086/0001209191-20-016086-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016088/0001209191-20-016088-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016090/0001209191-20-016090-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016092/0001209191-20-016092-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016095/0001209191-20-016095-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120034060/0001209191-20-034060-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120034065/0001209191-20-034065-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120034068/0001209191-20-034068-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120034076/0001209191-20-034076-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035025/0001209191-20-035025-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035029/0001209191-20-035029-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035031/0001209191-20-035031-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035032/0001209191-20-035032-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035033/0001209191-20-035033-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035034/0001209191-20-035034-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035056/0001209191-20-035056-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035059/0001209191-20-035059-index.htm
2020-07-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120041565/0001209191-20-041565-index.htm
2020-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120049398/0001209191-20-049398-index.htm
2020-04-08DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000123191920000022/0001231919-20-000022-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837018009771/0001558370-18-009771-index.htm
2019-01-188-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019000179/0001558370-19-000179-index.htm
2019-02-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019000521/0001558370-19-000521-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019002208/0001558370-19-002208-index.htm
2019-03-1810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1557746/000155837019002211/0001558370-19-002211-index.htm
2019-03-29S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1557746/000155837019002649/0001558370-19-002649-index.htm
2019-04-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019002790/0001558370-19-002790-index.htm
2019-04-25DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1557746/000155837019003262/0001558370-19-003262-index.htm
2019-04-25DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1557746/000155837019003265/0001558370-19-003265-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019004465/0001558370-19-004465-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1557746/000155837019004494/0001558370-19-004494-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019005495/0001558370-19-005495-index.htm
2019-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019005542/0001558370-19-005542-index.htm
2019-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019005736/0001558370-19-005736-index.htm
2019-07-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019006015/0001558370-19-006015-index.htm
2019-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019006557/0001558370-19-006557-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019007711/0001558370-19-007711-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1557746/000155837019007745/0001558370-19-007745-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019008497/0001558370-19-008497-index.htm
2019-09-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019008709/0001558370-19-008709-index.htm
2019-10-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019008878/0001558370-19-008878-index.htm
2019-10-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019008933/0001558370-19-008933-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019010383/0001558370-19-010383-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1557746/000155837019010425/0001558370-19-010425-index.htm
2019-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019011167/0001558370-19-011167-index.htm
2019-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019011272/0001558370-19-011272-index.htm
2020-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020000075/0001558370-20-000075-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020000132/0001558370-20-000132-index.htm
2020-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020001319/0001558370-20-001319-index.htm
2020-02-2510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1557746/000155837020001325/0001558370-20-001325-index.htm
2020-03-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020003444/0001558370-20-003444-index.htm
2020-04-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1557746/000155837020004176/0001558370-20-004176-index.htm
2020-04-23DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1557746/000155837020004178/0001558370-20-004178-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020005715/0001558370-20-005715-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1557746/000155837020005744/0001558370-20-005744-index.htm
2020-05-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1557746/000155837020005771/0001558370-20-005771-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020006658/0001558370-20-006658-index.htm
2020-05-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020006989/0001558370-20-006989-index.htm
2020-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020007276/0001558370-20-007276-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020007565/0001558370-20-007565-index.htm
2020-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020007743/0001558370-20-007743-index.htm
2020-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020009808/0001558370-20-009808-index.htm
2020-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1557746/000155837020009814/0001558370-20-009814-index.htm
2020-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020010689/0001558370-20-010689-index.htm
2020-09-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020011154/0001558370-20-011154-index.htm
2020-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020012486/0001558370-20-012486-index.htm
2020-11-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1557746/000155837020012488/0001558370-20-012488-index.htm
2019-02-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1557746/000161577419002509/0001615774-19-002509-index.htm
2020-04-29EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1557746/999999999520000907/9999999995-20-000907-index.htm
2018-12-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1557746/999999999718009613/9999999997-18-009613-index.htm
2019-05-09CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1557746/999999999719004164/9999999997-19-004164-index.htm

Aclaris Therapeutics, Inc (ACRS) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aclaris Therapeutics, Inc (ACRS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 964%
Institutional Ownership: 6613%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-03-02Neal WalkerPresident and CEOBuy96,150.001,025,053.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016095/0001209191-20-016095-index.htm
2020-03-02Kamil Ali-JacksonChief Legal OfficerBuy17,175.00103,978.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016073/0001209191-20-016073-index.htm
2020-03-02Neal WalkerPresident and CEOBuy52,564.001,049,994.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016095/0001209191-20-016095-index.htm
2020-06-01David N. GordonChief Medical OfficerBuy87,500.00106,940.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120034065/0001209191-20-034065-index.htm
2019-06-26James E Flynn10% Share HolderSell352.004.501,584.531,072,775.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000603/0001193805-19-000603-index.htm
2019-06-25James E Flynn10% Share HolderSell10,634.004.5147,947.641,073,127.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2019-06-24James E Flynn10% Share HolderSell13,063.004.5259,077.421,083,761.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2019-06-21James E Flynn10% Share HolderSell70,135.004.62323,701.081,096,824.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2020-06-01Neal WalkerPresident and CEOBuy73,014.001,107,907.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120034076/0001209191-20-034076-index.htm
2019-05-10James E Flynn10% Share HolderSell71,869.006.05434,749.951,166,959.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000485/0001193805-19-000485-index.htm
2020-09-01Neal WalkerPresident and CEOBuy83,092.001,170,023.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120049398/0001209191-20-049398-index.htm
2019-02-01Brett FairChief Commercial OfficerBuy3,875.0011,890.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119007486/0001209191-19-007486-index.htm
2019-05-09James E Flynn10% Share HolderSell172,800.006.161,064,016.001,238,828.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000485/0001193805-19-000485-index.htm
2020-06-01Kamil Ali-JacksonChief Legal OfficerBuy33,188.00132,387.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120034060/0001209191-20-034060-index.htm
2018-12-15Christopher PowalaChief Reg & Develop OfficerBuy1,300.00138,621.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063368/0001209191-18-063368-index.htm
2018-12-18Christopher PowalaChief Reg & Develop OfficerBuy1,625.00139,889.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063801/0001209191-18-063801-index.htm
2019-02-01Christopher PowalaChief Reg & Develop OfficerBuy3,400.00142,843.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119007489/0001209191-19-007489-index.htm
2018-12-15Frank RuffoChief Financial OfficerBuy1,300.00161,885.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063372/0001209191-18-063372-index.htm
2020-06-06Anand MehraDirectorBuy7,333.0016,209.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120035033/0001209191-20-035033-index.htm
2020-06-06ANDREW N SCHIFFDirectorBuy7,333.0016,209.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120035029/0001209191-20-035029-index.htm
2020-06-06Bryan M. ReasonsDirectorBuy7,333.0016,209.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120035059/0001209191-20-035059-index.htm
2020-06-06William D. HumphriesDirectorBuy7,333.0016,209.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120035032/0001209191-20-035032-index.htm
2018-12-18Frank RuffoChief Financial OfficerBuy1,250.00162,765.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063805/0001209191-18-063805-index.htm
2020-03-02Christopher P. MolineauxDirectorBuy8,876.0016,558.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016084/0001209191-20-016084-index.htm
2019-12-16Frank RuffoChief Financial OfficerBuy1,300.00166,276.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119061068/0001209191-19-061068-index.htm
2019-02-01Frank RuffoChief Financial OfficerBuy3,875.00166,284.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119007487/0001209191-19-007487-index.htm
2020-06-06Andrew Kenneth William PowellDirectorBuy7,333.0016,709.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120035031/0001209191-20-035031-index.htm
2019-12-18Frank RuffoChief Financial OfficerBuy1,250.00167,156.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119061540/0001209191-19-061540-index.htm
2020-02-03Frank RuffoChief Financial OfficerBuy3,875.00170,675.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120006667/0001209191-20-006667-index.htm
2020-03-02Frank RuffoChief Financial OfficerBuy25,750.00195,117.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016092/0001209191-20-016092-index.htm
2020-06-01Frank RuffoChief Financial OfficerBuy33,188.00221,143.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120034068/0001209191-20-034068-index.htm
2020-06-06Christopher P. MolineauxDirectorBuy7,333.0023,891.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120035034/0001209191-20-035034-index.htm
2020-03-02David N. GordonChief Medical OfficerBuy20,600.0024,952.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016065/0001209191-20-016065-index.htm
2018-12-15Stuart ShanlerChief Scientific OfficerBuy1,300.00268,812.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063370/0001209191-18-063370-index.htm
2018-12-18Stuart ShanlerChief Scientific OfficerBuy1,450.00269,892.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063803/0001209191-18-063803-index.htm
2019-02-01Stuart ShanlerChief Scientific OfficerBuy3,875.00273,355.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119007488/0001209191-19-007488-index.htm
2019-06-27James E Flynn10% Share HolderSell590,801.002.691,589,668.253,159,165.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000616/0001193805-19-000616-index.htm
2019-06-26James E Flynn10% Share HolderSell1,352.004.506,086.033,749,966.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000603/0001193805-19-000603-index.htm
2019-06-25James E Flynn10% Share HolderSell40,850.004.51184,188.573,751,318.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2019-06-24James E Flynn10% Share HolderSell50,177.004.52226,925.483,792,168.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2019-06-21James E Flynn10% Share HolderSell269,402.004.621,243,397.993,842,345.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2019-05-10James E Flynn10% Share HolderSell108,696.006.05657,523.844,111,747.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000485/0001193805-19-000485-index.htm
2019-05-09James E Flynn10% Share HolderSell261,345.006.161,609,231.844,220,443.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000485/0001193805-19-000485-index.htm
2020-03-02MAXINE GOWENDirectorBuy4,438.004,438.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016076/0001209191-20-016076-index.htm
2019-07-02David N. GordonChief Medical OfficerBuy6,000.006,000.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119041173/0001209191-19-041173-index.htm
2018-12-15Kamil Ali-JacksonChief Legal OfficerBuy1,733.0079,369.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063369/0001209191-18-063369-index.htm
2018-12-18Kamil Ali-JacksonChief Legal OfficerBuy1,075.0079,951.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063795/0001209191-18-063795-index.htm
2019-02-01Kamil Ali-JacksonChief Legal OfficerBuy3,875.0083,520.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119007485/0001209191-19-007485-index.htm
2019-12-16Kamil Ali-JacksonChief Legal OfficerBuy1,733.0083,945.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119061067/0001209191-19-061067-index.htm
2019-12-18Kamil Ali-JacksonChief Legal OfficerBuy1,075.0084,523.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119061536/0001209191-19-061536-index.htm
2018-12-18Brett FairChief Commercial OfficerBuy1,750.008,513.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063802/0001209191-18-063802-index.htm
2020-02-03Kamil Ali-JacksonChief Legal OfficerBuy3,875.0088,121.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120006666/0001209191-20-006666-index.htm
2020-03-02Anand MehraDirectorBuy8,876.008,876.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016081/0001209191-20-016081-index.htm
2020-03-02ANDREW N SCHIFFDirectorBuy8,876.008,876.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016090/0001209191-20-016090-index.htm
2020-03-02Bryan M. ReasonsDirectorBuy8,876.008,876.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016088/0001209191-20-016088-index.htm
2020-03-02William D. HumphriesDirectorBuy8,876.008,876.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016078/0001209191-20-016078-index.htm
2020-07-02David N. GordonChief Medical OfficerBuy6,000.0088,895.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120041565/0001209191-20-041565-index.htm
2018-12-15Neal WalkerPresident and CEOBuy3,033.00908,895.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063373/0001209191-18-063373-index.htm
2018-12-18Neal WalkerPresident and CEOBuy2,925.00910,957.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063804/0001209191-18-063804-index.htm
2019-12-16Neal WalkerPresident and CEOBuy3,033.00920,378.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119061069/0001209191-19-061069-index.htm
2019-02-01Neal WalkerPresident and CEOBuy10,800.00920,924.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119007490/0001209191-19-007490-index.htm
2019-12-18Neal WalkerPresident and CEOBuy2,925.00922,521.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119061545/0001209191-19-061545-index.htm
2020-02-03Neal WalkerPresident and CEOBuy10,800.00932,578.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120006668/0001209191-20-006668-index.htm
2020-03-02Andrew Kenneth William PowellDirectorBuy8,876.009,376.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016086/0001209191-20-016086-index.htm
2019-06-27James E Flynn10% Share HolderSell108,674.002.69292,409.13964,101.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000616/0001193805-19-000616-index.htm